New York State Common Retirement Fund
RAPP

New York State Common Retirement Fund’s Rapport Therapeutics RAPP Stock Holding History

New York State Common Retirement Fund’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
10,300
-700
-6% -$25.7K ﹤0.01% 2073
2026
Q1 		$344K Buy
11,000
+3,700
+51% +$104K ﹤0.01% 2042
2025
Q4 		$221K Hold
7,300
– – ﹤0.01% 2256
2025
Q3 		$217K Buy
7,300
+3,800
+109% +$67.8K ﹤0.01% 2259
2025
Q2 		$39.8K Hold
3,500
– – ﹤0.01% 3002
2025
Q1 		$35.1K Hold
3,500
– – ﹤0.01% 2876
2024
Q4 		$62.1K Buy
+3,500
New +$77.6K ﹤0.01% 2790

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

New York State Common Retirement Fund's RAPP Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Rapport Therapeutics (RAPP) stake by 6.4% in Q2 2026, selling an estimated $25.7K and leaving 10,300 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

New York State Common Retirement Fund first reported a position in RAPP in Q4 2024 and has held it in 7 quarters since. 160 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • New York State Common Retirement Fund held 10,300 shares of Rapport Therapeutics worth $429K as of Q2 2026.
  • New York State Common Retirement Fund sold 700 Rapport Therapeutics shares in Q2 2026, an estimated $25.7K.
  • Rapport Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2073 holding.
  • New York State Common Retirement Fund first reported a position in Rapport Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 160 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.